+A -A

Comparative View:

Create chart
Net sales revenues
Change in Fair Value of Biological Assets
Cost of Goods Sold
Depreciation / Amortization / exhaustion
Exhaustion of biological assets
Gross Profit
Selling Expenses
General and Administrative Expenses
Management Compensation
Other Operating Compensation
Equity income from subsidiaries
Operating Profit before Financial Income and Equity
Financial Income
Financial Expenses
Income Before Income Tax and Social Contribution
Income and social contribution taxes - current
Income Tax and Social Contribution - Deferred
Effect profit from discontinued operation
Net Income
Recurring Net Income
Recurring EBITDA

* Because of the date of the merger between Duratex and Satipel, 31.08.09, include data only from the "old" Duratex

**from 1Q 12 the data does not include discontinued operation, Deca Piazza